Lara Costa has studied the effects of serotonin on synaptic transmission in the hippocampus, showing that activation of 5-HT7 receptors reverses hippocampal mGluR-LTD in wild-type mice and in a mouse model of Fragile X Syndrome. She, also, has studied the use of new synthesis agonists for 5-HT7 receptors as a possible novel therapeutic strategy in FXS and the intracellular pathways activated by 5-HT7 receptors.Now, she is studying the peripheral and spinal processing of pain in on CRND8 mice, the transgenic mouse models of Alzheimer’s Disease. She is investigating the question of whether Aß normally controls pain transmission in the spinal dorsal horn (DH) and if a few number of relevant conditions may intervene to alter this control. She has also characterized the modulatory effects exerted by the endogenous neuropeptide PACAP on AMPA-receptor mediated synaptic currents in the hippocampus and identified the receptors and intracellular messengers involved..She has performed patch clamp recordings from rat hippocampal neurons to test the biological effects of new ligands with high affinity on either AMPA or NMDA receptors for glutamate, with the final objective of finding new pharmacological tools in the therapy of neurodegenerative diseases.